Bispecific CD3 and CD19 antigen binding constructs
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- ZYMEWORKS INC
- Publication Date
- 2016-04-27
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS
[0002] This application claims U.S. Provisional Application Nos. 61 / 845,948, filed July 12, 2013 and U.S. Provisional Application Nos. 61 / 927,877, filed January 15, 2014 and 61 / 978,719, filed April 11, 2014 Benefits of U.S. Provisional Applications. These applications are hereby incorporated by reference in their entirety.
[0003] sequence listing
[0004] This application contains a Sequence Listing, which has been submitted via EFS-Web and is hereby incorporated by reference in its entirety. The ASCII copy was created in XX, 2014, named XXXXX_CRF_sequencelisting.txt, and the size is XXX,XXX bytes. technical field
[0005] The field of the invention is the rational design of multispecific scaffolds, such as antigen binding constructs comprising CD3 binding domains for custom development of biotherapeutics. Background of the invention
[0006] In the field of therapeutic proteins, antibodies with their multivalent target ...